SCHEMBL4922429

SCHEMBL4922429

Cc1ccc2oc(=O)ccc2c1N

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 9/20 0.47
▸ KDM4E B2RXH2 8/20 0.47
▸ HSD17B10 Q99714 7/20 0.47
▸ HPGD P15428 7/20 0.47
▸ GAA P10253 5/20 0.47
▸ GLA P06280 3/20 0.47
▸ CA12 O43570 2/20 0.47
▸ CASP1 P29466 2/20 0.47
▸ CASP7 P55210 2/20 0.47
▸ CA9 Q16790 2/20 0.47
▸ CA1 P00915 1/20 0.47
▸ CYP2A6 P11509 3/20 0.43
▸ MAOB P27338 2/20 0.43
▸ MAOA P21397 1/20 0.43
▸ CYP1A2 P05177 2/20 0.41
▸ NCOA1 Q15788 1/20 0.41
▸ CYP1A1 P04798 1/20 0.41
▸ CYP1B1 Q16678 1/20 0.41
▸ LMNA P02545 2/20 0.40
▸ GFER P55789 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14627838 0.81 NQO1 (0.44) ALDH1A1KDM4EHSD17B10HPGDGAA
SCHEMBL8750135 0.80 CYP2A6 (0.46) ALDH1A1KDM4EHSD17B10HPGDGAA
SCHEMBL30954677 0.80 CYP2A6 (0.46) ALDH1A1KDM4EHSD17B10HPGDGAA
SCHEMBL8247621 0.77 CYP2A6 (0.43) ALDH1A1KDM4EHSD17B10HPGDGAA
SCHEMBL8750110 0.74 CYP2A6 (0.45) ALDH1A1KDM4EHSD17B10HPGDGLA
SCHEMBL21665558 0.72 CYP1A2 (0.47) ALDH1A1KDM4EHSD17B10HPGDGAA
SCHEMBL546445 0.72 CYP2A6 (0.59) ALDH1A1KDM4EHSD17B10HPGDGAA
SCHEMBL2169023 0.72 ALDH1A1 (0.74) ALDH1A1KDM4EHSD17B10HPGDGAA
SCHEMBL9480286 0.72 ALDH1A1 (0.50) ALDH1A1KDM4EHSD17B10HPGDGAA
SCHEMBL4923328 0.72 ALDH1A1 (0.47) ALDH1A1CYP2A6MAOBMAOALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080194522-A1 Development of Fluorogenic Substrates For Monoamine Oxidases (Mao-A and Mao-B) TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, THE 2008-08-14 — — US disclosed
US-20080194522-A1 Development of Fluorogenic Substrates For Monoamine Oxidases (Mao-A and Mao-B) TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, THE 2008-08-14 — — US disclosed
US-20080194522-A1 Development of Fluorogenic Substrates For Monoamine Oxidases (Mao-A and Mao-B) TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, THE 2008-08-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080194522-A1 Development of Fluorogenic Substrates For Monoamine Oxidases (Mao-A and Mao-B) MAOA, MAOB, COMT ALDH1A1 181/4885KDM4E 1183/4885HSD17B10 336/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback